Ra Capital Management as of June 30, 2019
Portfolio Holdings for Ra Capital Management
Ra Capital Management holds 25 positions in its portfolio as reported in the June 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ascendis Pharma A S (ASND) | 25.5 | $476M | 4.1M | 115.15 | |
| Wave Life Sciences (WVE) | 10.9 | $203M | 7.8M | 26.09 | |
| Zogenix | 9.6 | $178M | 3.7M | 47.78 | |
| Ra Pharmaceuticals | 7.3 | $137M | 4.9M | 28.19 | |
| Synthorx | 7.0 | $131M | 9.7M | 13.51 | |
| Eidos Therapeutics | 6.0 | $113M | 2.2M | 52.12 | |
| Orchard Therapeutics Plc ads | 3.8 | $72M | 5.1M | 13.99 | |
| Tg Therapeutics (TGTX) | 3.2 | $60M | 6.9M | 8.65 | |
| Myovant Sciences | 3.2 | $59M | 6.5M | 9.05 | |
| Crinetics Pharmaceuticals In (CRNX) | 2.5 | $47M | 1.9M | 25.00 | |
| Rhythm Pharmaceuticals (RYTM) | 2.2 | $42M | 1.9M | 22.00 | |
| Dicerna Pharmaceuticals | 2.1 | $39M | 2.5M | 15.75 | |
| Arvinas Ord (ARVN) | 2.0 | $37M | 1.7M | 21.99 | |
| Prevail Therapeutics Ord | 1.9 | $36M | 2.7M | 13.20 | |
| Axsome Therapeutics (AXSM) | 1.9 | $35M | 1.3M | 25.75 | |
| Stoke Therapeutics (STOK) | 1.8 | $33M | 1.1M | 29.17 | |
| Kala Pharmaceuticals | 1.6 | $29M | 4.5M | 6.38 | |
| Shockwave Med | 1.5 | $28M | 496k | 57.09 | |
| Precision Biosciences Ord | 1.3 | $24M | 1.8M | 13.25 | |
| Solid Biosciences | 1.1 | $21M | 2.7M | 7.92 | |
| Alector (ALEC) | 1.0 | $19M | 1.0M | 19.00 | |
| G1 Therapeutics | 0.8 | $15M | 484k | 30.66 | |
| X4 Pharmaceuticals (XFOR) | 0.7 | $13M | 861k | 15.00 | |
| Scpharmaceuticals (SCPH) | 0.6 | $10M | 3.2M | 3.19 | |
| Odonate Therapeutics Ord | 0.4 | $7.3M | 200k | 36.69 |
